83-2272-63 [受注停止]KRIBIOLISA Vibecotamab ELISA 1 x 96 wells KBI1773
[KRISHGEN BioSystems]特徴
- Description:ELISA for the detection of bispecific antibody Vibecotamab in human serum and plasma.
- Lead time for this kit is 5 weeks.
- About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity.
- - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year.Vibecotamab, a CD3-CD123 bispecific antibody, stimulates targeted T cell-mediated killing of CD123-expressing cells, regardless of T cell antigen specificity.
- It is a full-length immunoglobulin molecule designed to be dosed intermittently.
- Multiple trials are ongoing to investigate its therapeutic effects in patients with AML.
仕様
- サイズ:1 x 96 wells
- Reactivity:Human
- アプリケーション:ELISA,Immunoassay
- Sensitivity:Please refer to the current IFU for the updated calibrator range and sensitivity.
- Calibration Range:0 ug/ml - 100 ug/ml
- サンプルタイプ:Human serum and plasma
- 測定方法:Colorimetric, 450nm
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





